Nothing Special   »   [go: up one dir, main page]

SE8204288D0 - APAP ANTICIDUM composition - Google Patents

APAP ANTICIDUM composition

Info

Publication number
SE8204288D0
SE8204288D0 SE8204288A SE8204288A SE8204288D0 SE 8204288 D0 SE8204288 D0 SE 8204288D0 SE 8204288 A SE8204288 A SE 8204288A SE 8204288 A SE8204288 A SE 8204288A SE 8204288 D0 SE8204288 D0 SE 8204288D0
Authority
SE
Sweden
Prior art keywords
anticidum
apap
composition
antiacid
aminophenol
Prior art date
Application number
SE8204288A
Other languages
Swedish (sv)
Other versions
SE8204288L (en
Inventor
F J Sterbenz
L Weintraub
G L Cohen
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8204288D0 publication Critical patent/SE8204288D0/en
Publication of SE8204288L publication Critical patent/SE8204288L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A therapeutic dose comprising 60-1200 mg of a conventional antiacid component and 150-2000 mg of N-acetyl-p-aminophenol makes possible an increased rate of absorption of the latter into the blood stream of a subject. The compositions may be administered orally and may also comprise aspirin, phenylpropanolamine hydrochloride, chlorpheniramine maleate, and dextromethorphan hydrobromide.
SE8204288A 1981-07-13 1982-07-12 ANALGETIC COMPOSITION CONTAINING N-ACETYL-P-AMINOPHENOL IN COMBINATION WITH AN ANTACIDUM SE8204288L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28256581A 1981-07-13 1981-07-13

Publications (2)

Publication Number Publication Date
SE8204288D0 true SE8204288D0 (en) 1982-07-12
SE8204288L SE8204288L (en) 1983-01-14

Family

ID=23082085

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204288A SE8204288L (en) 1981-07-13 1982-07-12 ANALGETIC COMPOSITION CONTAINING N-ACETYL-P-AMINOPHENOL IN COMBINATION WITH AN ANTACIDUM

Country Status (17)

Country Link
JP (1) JPS5823617A (en)
KR (1) KR840000234A (en)
AR (1) AR228661A1 (en)
AU (1) AU8436082A (en)
BE (1) BE893827A (en)
CA (1) CA1182049A (en)
DE (1) DE3226178A1 (en)
DK (1) DK309282A (en)
FR (1) FR2509174A1 (en)
GB (1) GB2103087A (en)
GR (1) GR76197B (en)
IT (1) IT1148199B (en)
NL (1) NL8202773A (en)
NO (1) NO822385L (en)
PT (1) PT75234B (en)
SE (1) SE8204288L (en)
ZA (1) ZA823760B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19502789A1 (en) * 1995-01-28 1996-08-01 Dirk Krischenowski Medicament contg. analgesic, antacid, and/or vitamin etc.
WO1998032434A1 (en) * 1997-01-29 1998-07-30 Chong Kun Dang Corp. New analgesic composition
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
DE102004042139B4 (en) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Peroral dosage forms to achieve a retarding effect after drug intake with a meal
PE20061125A1 (en) * 2004-10-28 2006-11-08 Novartis Ag PHARMACEUTICAL COMPOSITION INCLUDING ACETAMINOPHEN, CAFFEINE AND OPTIONALLY ASPIRIN TOGETHER WITH AN ALKALINE AGENT
EP3449928A1 (en) 2005-11-28 2019-03-06 Imaginot Pty Ltd. Oral therapeutic compound delivery system
GB0607085D0 (en) 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
GB0813929D0 (en) * 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241201A (en) * 1968-07-23 1971-08-04 Sterling Winthrop Group Ltd Improvements in or relating to effervescent pharmaceutical compositions
GB1221038A (en) * 1969-09-18 1971-02-03 H & T Kirby & Company Ltd Improvements in effervescent tablet compositions
GB1359614A (en) * 1971-04-06 1974-07-10 Dev Et De Rech Soc Fr De Method for the manufacture of effervescent tablets

Also Published As

Publication number Publication date
GB2103087A (en) 1983-02-16
KR840000234A (en) 1984-02-18
CA1182049A (en) 1985-02-05
FR2509174A1 (en) 1983-01-14
ZA823760B (en) 1983-03-30
PT75234B (en) 1985-10-04
NL8202773A (en) 1983-02-01
IT8248788A0 (en) 1982-07-09
IT1148199B (en) 1986-11-26
DK309282A (en) 1983-01-14
GR76197B (en) 1984-08-03
JPS5823617A (en) 1983-02-12
SE8204288L (en) 1983-01-14
PT75234A (en) 1982-08-01
NO822385L (en) 1983-01-14
AU8436082A (en) 1983-01-20
AR228661A1 (en) 1983-03-30
BE893827A (en) 1983-01-12
DE3226178A1 (en) 1983-01-20

Similar Documents

Publication Publication Date Title
ES8505519A1 (en) Analgesic, antagonist, and/or anorectic 14-fluoromorphinans.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
IT1190727B (en) COMPOUND WITH ANALGESIC, ANTI-INFLAMMATORY AND MUCOREGULATING ACTIVITY PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
ITRM920155A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 3-2 (DIMETHYLAMINE) ETHYL-N-METHYL-INDOL-5-METHANAL SULPHONAMIDE, RELATIVE PROCEDURE FOR PREPARATION AND USE OF THE SAME IN TREATMENT OF MAMMALS
NO922004L (en) ORAL PREPARATION FOR TREATMENT OF INFLAMMATORY GAS DISORDERS
FR2622798B1 (en) DOSAGE FORM AND OSMOTIC DELIVERY DEVICE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
SE8204288D0 (en) APAP ANTICIDUM composition
CA2032475A1 (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
ATE38151T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING STABLE 5-ADENOSYL-L-METHIONINE SALTS FOR ORAL USE.
ES2176805T3 (en) USE OF MIXTURES OF ACTIVE PRODUCTS FOR THE OBTAINING OF HYPOCOLESTERINEMIC AGENTS.
DE3875611D1 (en) PHARMACEUTICAL COMPOSITIONS.
IL70407A (en) Synergistic analgesic pharmaceutical compositions in unit dosage form,comprising an analgesic agent and hydroxyzine
SE8402199L (en) PHARMACEUTICAL PREPARATION CONTAINING CO-DERGOCRIN AND A CALCIUM ANTAGONIST
IT8219216A0 (en) AND RELATED PHARMACEUTICAL COMPOSITIONS COMPOSED WITH ANTI-INFLAMMATIC, ANALGESIC AND MUCOREGULATORY ACTIVITIES, PROCEDURE FOR ITS PREPARATION
DK0483320T3 (en) Prolonged-release pharmaceutical compositions for oral administration and methods for their preparation
IT8219453A0 (en) PHARMACEUTICAL COMPOSITION ANALGESIC, ANTIPYRETIC AND ANTI-INFLAMMATORY SUITABILITY AND PROCEDURE FOR THE PREPARATION OF THE ACTIVE INGREDIENT.
IT8222730A0 (en) COMPOUND WITH ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY, ITS PREPARATION PROCEDURE AND RELATED PHARMACEUTICAL COMPOSITIONS
IT8320325A0 (en) COMPOUND WITH ANALGESIC, ANTIPYRETIC, ANTI-INFLAMMATORY AND MUSCLE RELAXING ACTIVITIES, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
Aloj et al. Clinic evaluation of kedacillin in complicated biliary surgery.
SE8304818L (en) MEDICINE WITH ANTICULAR, SPASMOLYTIC AND LOCAL ANESTIC EFFECTS
IT8219215A0 (en) COMPOUND WITH ANALGESIC, ANTI-INFLAMMATORY AND MUCOREGULATORY ACTIVITIES, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
IT8221907A0 (en) NEW COMPOUND WITH ANALGESIC, ANTIPYRETIC, ANTI-INFLAMMATORY AND MUSCLE RELAXING ACTIVITIES, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
RU2000111645A (en) METHOD FOR TREATING HEMORRHAGIC FEVER WITH RENAL SYNDROME
KR927003530A (en) Use of local anesthetics in the manufacture of pharmaceutical formulations for iontophoresis
IT8420355A0 (en) DERIVATIVE OF P-AMINOPHENOL WITH MUCOSECRETOLYTIC-FLUIDIFYING AND ANTIPYRETIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND ITS PHARMACEUTICAL COMPOSITIONS.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8204288-8

Effective date: 19840615

Format of ref document f/p: F